Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-24 @ 7:16 PM
NCT ID:
NCT05140603
Eligibility Criteria:
Inclusion Criteria:
* Older than 18 years HIV-1 infected subjects.
* Switched to a doravirine-based ART regimen under clinician criteria.
Exclusion Criteria:
* Doravirine major resistance mutations (accessory mutations are allowed).
* Major mutations to any of the other drugs combined with doravirine.
* Pregnancy, active tuberculosis or any condition that contraindicate the use of doravirine.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05140603
Study Brief:
Protocol Section:
NCT05140603